However, in this study, the prognostic deterioration due to these two molecular features was not related to the presence or absence of hemorrhage, and we, therefore, speculate that the prognostic impact of the angiogenic effects of EGFR and FGFR2 is more likely to arise through the promotion of tumor proliferation and migration than through hemorrhage. This evidence concerns the gene FGFR2 and neoplasm.